Dr. Michael King, DPM

NPI: 1326153339
Total Payments
$191,256
2024 Payments
$62,982
Companies
21
Transactions
280

Payment Breakdown by Category

Other$131,370 (68.7%)
Travel$47,134 (24.6%)
Consulting$7,568 (4.0%)
Food & Beverage$5,161 (2.7%)
Education$25.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $116,715 46 61.0%
Travel and Lodging $47,134 139 24.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $14,655 9 7.7%
Consulting Fee $7,568 9 4.0%
Food and Beverage $5,161 76 2.7%
Education $25.00 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Averitas Pharma Inc. $153,333 199 $0 (2024)
GRT US Holding, Inc. $29,445 36 $0 (2022)
Modulated Imaging, Inc. $5,449 10 $0 (2021)
Heron Therapeutics, Inc. $1,521 2 $0 (2021)
Organogenesis Inc. $485.40 5 $0 (2022)
Cipher Pharmaceuticals US LLC $389.03 2 $0 (2017)
Horizon Pharma plc $148.41 5 $0 (2018)
Smith+Nephew, Inc. $109.31 4 $0 (2023)
Integra LifeSciences Corporation $73.76 1 $0 (2017)
Boston Scientific Corporation $69.68 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $62,982 86 Averitas Pharma Inc. ($62,867)
2023 $90,501 119 Averitas Pharma Inc. ($90,466)
2022 $29,724 40 GRT US Holding, Inc. ($29,445)
2021 $2,313 5 Heron Therapeutics, Inc. ($1,521)
2020 $647.50 1 Modulated Imaging, Inc. ($647.50)
2019 $4,275 9 Modulated Imaging, Inc. ($4,246)
2018 $180.89 6 Horizon Pharma plc ($126.51)
2017 $633.22 14 Cipher Pharmaceuticals US LLC ($389.03)

All Payment Transactions

280 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
11/01/2024 Stryker Corporation SALVATION (Device) Food and Beverage In-kind items and services $14.71 General
Category: TRAUMA & EXTREMITIES
10/30/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $51.07 General
Category: PAIN MANAGEMENT
10/23/2024 Averitas Pharma Inc. QUTENZA (Drug) Consulting Fee Cash or cash equivalent $1,660.00 General
Category: PAIN MANAGEMENT
10/16/2024 Averitas Pharma Inc. QUTENZA (Drug) Honoraria Cash or cash equivalent $3,000.00 General
Category: PAIN MANAGEMENT
10/16/2024 Averitas Pharma Inc. QUTENZA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $1,452.50 General
Category: PAIN MANAGEMENT
10/16/2024 Averitas Pharma Inc. QUTENZA (Drug) Travel and Lodging Cash or cash equivalent $73.18 General
Category: PAIN MANAGEMENT
10/16/2024 Averitas Pharma Inc. QUTENZA (Drug) Travel and Lodging Cash or cash equivalent $66.61 General
Category: PAIN MANAGEMENT
10/16/2024 Averitas Pharma Inc. QUTENZA (Drug) Travel and Lodging Cash or cash equivalent $48.25 General
Category: PAIN MANAGEMENT
10/16/2024 Averitas Pharma Inc. QUTENZA (Drug) Travel and Lodging Cash or cash equivalent $46.68 General
Category: PAIN MANAGEMENT
10/16/2024 Averitas Pharma Inc. QUTENZA (Drug) Travel and Lodging Cash or cash equivalent $11.10 General
Category: PAIN MANAGEMENT
10/08/2024 Averitas Pharma Inc. QUTENZA (Drug) Travel and Lodging In-kind items and services $834.96 General
Category: PAIN MANAGEMENT
10/08/2024 Averitas Pharma Inc. QUTENZA (Drug) Travel and Lodging In-kind items and services $231.56 General
Category: PAIN MANAGEMENT
10/08/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: PAIN MANAGEMENT
09/30/2024 Averitas Pharma Inc. QUTENZA (Drug) Honoraria Cash or cash equivalent $3,000.00 General
Category: PAIN MANAGEMENT
09/30/2024 Averitas Pharma Inc. QUTENZA (Drug) Honoraria Cash or cash equivalent $207.50 General
Category: PAIN MANAGEMENT
08/28/2024 Averitas Pharma Inc. QUTENZA (Drug) Honoraria Cash or cash equivalent $3,000.00 General
Category: PAIN MANAGEMENT
08/28/2024 Averitas Pharma Inc. QUTENZA (Drug) Travel and Lodging Cash or cash equivalent $111.79 General
Category: PAIN MANAGEMENT
08/28/2024 Averitas Pharma Inc. QUTENZA (Drug) Travel and Lodging Cash or cash equivalent $49.18 General
Category: PAIN MANAGEMENT
08/28/2024 Averitas Pharma Inc. QUTENZA (Drug) Travel and Lodging Cash or cash equivalent $47.18 General
Category: PAIN MANAGEMENT
08/21/2024 Averitas Pharma Inc. QUTENZA (Drug) Honoraria Cash or cash equivalent $415.00 General
Category: PAIN MANAGEMENT
08/15/2024 Averitas Pharma Inc. QUTENZA (Drug) Travel and Lodging In-kind items and services $531.95 General
Category: PAIN MANAGEMENT
08/15/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $57.15 General
Category: PAIN MANAGEMENT
08/09/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $30.40 General
Category: PAIN MANAGEMENT
07/24/2024 Averitas Pharma Inc. QUTENZA (Drug) Honoraria Cash or cash equivalent $3,000.00 General
Category: PAIN MANAGEMENT
07/24/2024 Averitas Pharma Inc. QUTENZA (Drug) Honoraria Cash or cash equivalent $415.00 General
Category: PAIN MANAGEMENT

About Dr. Michael King, DPM

Dr. Michael King, DPM is a Podiatrist healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326153339.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael King, DPM has received a total of $191,256 in payments from pharmaceutical and medical device companies, with $62,982 received in 2024. These payments were reported across 280 transactions from 21 companies. The most common payment nature is "Honoraria" ($116,715).

Practice Information

  • Specialty Podiatrist
  • Other Specialties Foot & Ankle Surgery, Podiatrist
  • Location Nashville, TN
  • Active Since 08/20/2006
  • Last Updated 08/29/2023
  • Taxonomy Code 213E00000X
  • Entity Type Individual
  • NPI Number 1326153339

Products in Payments

  • QUTENZA (Drug) $153,333
  • Qutenza (Drug) $29,445
  • Clarifi Imaging System (Device) $5,449
  • Zynrelef (Drug) $1,521
  • NUVAIL (Device) $389.03
  • Puraply (Medical Supply) $248.09
  • Affinity (Medical Supply) $237.31
  • KRYSTEXXA (Drug) $109.90
  • Omnigraft (Device) $73.76
  • Santyl (Drug) $43.76
  • Pico 14 (Device) $34.76
  • GENERAL - PAIN MANAGEMENT (Device) $31.83
  • GRAFIX PL (Medical Supply) $30.79
  • KRYSTEXXA (Biological) $28.57
  • DUEXIS (Drug) $27.58
  • LUZU LULICONAZOLE (Drug) $27.55
  • Kerecis Omega3 SurgiClose (Device) $25.98
  • GRAFIX/GRAFIXPL/STRAVIX (Biological) $20.47
  • JUBLIA EFINACONAZOLE (Drug) $18.57
  • Autotome RX 49 (Device) $17.62

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Podiatrist Doctors in Nashville